help button home button Biophys. J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Originally published as Biophys J. BioFAST on July 29, 2005.
doi:10.1529/biophysj.104.054080
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
biophysj.104.054080v1
89/4/2286    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roth, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roth, C. M.
Biophysical Journal 89:2286-2295 (2005)
© 2005 The Biophysical Society

Molecular and Cellular Barriers Limiting the Effectiveness of Antisense Oligonucleotides

Charles M. Roth

Department of Chemical and Biochemical Engineering, Department of Biomedical Engineering, Rutgers University, Piscataway, New Jersey 08854-8058

Correspondence: Address reprint requests to Charles M. Roth, Dept. of Chemical and Biochemical Engineering, Dept. of Biomedical Engineering, Rutgers University, 98 Brett Rd., Rm. C-228, Piscataway, NJ 08854-8058. Tel.: 732-445-4109; Fax: 732-445-2581; E-mail: cmroth{at}rci.rutgers.edu.

Antisense oligonucleotides present a powerful means to inhibit expression of specific genes, but their effectiveness is limited by factors including cellular delivery, biochemical attack, and poor binding to target. We have developed a systems model of the processes required for an antisense oligonucleotide to enter, gain access to its target mRNA, and exert activity in a cell. The model accurately mimics observed trends in antisense effectiveness with the stability of the oligonucleotide backbone and with the affinity/kinetics of binding to the mRNA over the time course of inhibition. By varying the model parameters within the physically realizable range, we note that the major molecular and cellular barriers to antisense effectiveness are intracellular trafficking, oligonucleotide-mRNA binding rate, and nuclease degradation of oligonucleotides, with a weaker dependence on total cellular uptake than might be expected. Furthermore, the model may serve as a predictive tool to design and test strategies for the cellular use of antisense oligonucleotides. The use of integrated mathematical modeling can play a significant role in the development of antisense and related technologies.




This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
D. W. Bartlett and M. E. Davis
Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging
Nucleic Acids Res., January 12, 2006; 34(1): 322 - 333.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Biophysical Society.